Metabolic steatotic liver disease : current knowledge, therapeutic treatments, and future directions /
Provides the most updated research findings and defines the current data gaps on metabolic fatty liver disease. The book extensively covers key areas in metabolic fatty liver disease research, including epidemiology (adults and children), economic burden, patient-reported outcome burden, natural his...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
London ; San Diego, CA :
Academic Press,
[2024]
|
| Subjects: | |
| Online Access: | ScienceDirect |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | on1442323728 | ||
| 003 | OCoLC | ||
| 005 | 20260915095214.0 | ||
| 006 | m o d | ||
| 007 | cr unu|||uuuuu | ||
| 008 | 240627s2024 enk ob 001 0 eng d | ||
| 040 | |a YDX |b eng |e rda |c YDX |d OPELS |d OCLCO |d EMU |d OCLCO |d OCLCL |d BNG |d OCLCF |d OCLCO | ||
| 020 | |a 9780323996501 |q (electronic bk.) | ||
| 020 | |a 0323996507 |q (electronic bk.) | ||
| 020 | |z 9780323996495 | ||
| 020 | |z 0323996493 | ||
| 035 | |a (OCoLC)1442323728 | ||
| 050 | 4 | |a RC848.F3 | |
| 082 | 0 | 4 | |a 616.3/62 |2 23/eng/20240709 |1 https://id.oclc.org/worldcat/ddc/E4cvQTy99pJKQk8ymYYhCK9Jp3 |
| 245 | 0 | 0 | |a Metabolic steatotic liver disease : |b current knowledge, therapeutic treatments, and future directions / |c edited by Mindie Nguyen, Linda Henry. |
| 264 | 1 | |a London ; |a San Diego, CA : |b Academic Press, |c [2024] | |
| 264 | 4 | |c ©2024 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a Provides the most updated research findings and defines the current data gaps on metabolic fatty liver disease. The book extensively covers key areas in metabolic fatty liver disease research, including epidemiology (adults and children), economic burden, patient-reported outcome burden, natural history, current treatments, current diagnostic methods, controversies (NAFLD/MAFLD), current guidelines, fatty liver disease in the presence of other liver diseases as well as guidance on future research. This book will provide translational researchers with a current and comprehensive resource dedicated to all aspects of research in metabolic fatty liver disease, identify current gaps in research and make future research recommendations. It also offers clinicians a look at important background information in metabolic fatty liver disease and thoroughly reviews the latest research in this area to inform treatment outcomes. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Online resource; title from digital title page (viewed on May 12, 2026). | |
| 505 | 0 | |a Global epidemiology of NAFLD / Margaret L.P. Teng, Cheng Han Ng, Mark Muthiah, Mindie H. Nguyen, Daniel Q. Huang -- The epidemiology of non-alcoholic fatty liver disease in the United States / Yee Hui Yeo, Linda Henry and Mindie H. Nguyen -- Economic and patient reported outcome burden of NAFLD / Pegah Golabi and Zobair M. Younossi -- Pathogenesis of NAFLD/NASH / Juliane I. Beier, Valentina Medici, Sean Spencer, Weiguo Fan, Natalie J. T̲r̲k -- Natural history of nonalcoholic fatty liver disease / Dominic Crocombe and Emmanuel A. Tsochatzis -- Clinical diagnosis and evaluation pathway / Robert Lam, Bubu A. Banini, Albert Do, Joseph K. Lim -- Nonalcoholic fatty liver disease-related extrahepatic complications, associated outcomes, and their treatment considerations / Joo Hyun Oh and Dae Won Jun -- Metabolic comorbidities, endocrine--Diabetes, polycystic ovarian syndrome, thyroid dysfunction / Rui-Xu Yang and Jian-Gao Fan -- Noninvasive, serum-based evaluation of liver fibrosis in metabolic (dysfunction)-associated fatty liver disease / Eda Kaya and Yusuf Yilmaz -- Noninvasive evaluation of liver fibrosis in MASLD--Imaging/elastography based / Xinrong Zhang, Guanlin Li, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong -- Clinical management of MASLD and MASH--An overview / Paul Horn and Philip N. Newsome -- Nonpharmacologic and nonsurgical treatment of NAFLD/NASH, obesity, and metabolic disease / Oluwafemi O. Balogun, Emad S. Shaikh and Kathleen E. Corey -- Pharmacologic treatment of NAFLD/NASH and their related comorbidities / Sun H. Kim and Paul Y. Kwo -- Surgical treatment of obesity for NAFLD / Donald Goens, Crystal N. Johnson-Mann, Amir Zarrinpar, Heather Patton -- Metabolic dysfunction-associated steatotic liver disease in children and adolescents / Katherine Cheng and Philip Rosenthal -- Fatty liver and viral hepatitis: Prevalence, risk factors, natural course, pathogenesis, and management / Ming-Lun Yeh, Jee-Fu Huang and Ming-Lung Yu -- Lean NAFLD: Prevalence, risk factors/pathogenesis, natural history, and treatment / Takanori Ito and Hirokazu Takahashi -- Future directions for fatty liver disease / Anna Di Bartolomeo and Jacob George. | |
| 650 | 0 | |a Fatty liver. | |
| 650 | 2 | |a Fatty Liver |0 (DNLM)D005234 | |
| 650 | 6 | |a Stéatose hépatique. |0 (CaQQLa)201-0087079 | |
| 650 | 7 | |a Fatty liver |2 fast |0 (OCoLC)fst00921974 | |
| 700 | 1 | |a Nguyen, Mindie H., |e editor. | |
| 700 | 1 | |a Henry, Linda |q (Linda L.), |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Metabolic steatotic liver disease. |d London ; San Diego, CA : Academic Press, [2024] |z 0323996493 |z 9780323996495 |w (OCoLC)1361676194 |
| 856 | 4 | 0 | |3 ScienceDirect |u https://www.sciencedirect.com/science/book/9780323996495 |